Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and nutrient supplements for airflow obstruction in ex-smokers
ACTRN12609000272291Phase 3Terminated
- Sponsor
- NHMRC Centre for Clinical Research Excellence in Respiratory and Sleep Medicine
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of simvastatin in chronic obstructive pulmonary disease (COPD) and Airflow Limitation (4 arms), sponsored by NHMRC Centre for Clinical Research Excellence in Respiratory and Sleep Medicine. Primary endpoints: Forced expiratory volume in 1 second, Forced vital capacity and 2 more. Started Aug 2009; status: terminated.
02
Drugs
simvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)Airflow Limitation
Beyond the preview
Go deeper on ACTRN12609000272291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000272291.